Skip to content

Virtual Reality to Alleviate Claustrophobia During MRI

Evaluation of the Benefit of Virtual Reality to Alleviate Claustrophobia During MRI Clinical Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04754958
Acronym
CLAUSTROVR
Enrollment
24
Registered
2021-02-15
Start date
2021-07-20
Completion date
2024-02-28
Last updated
2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Claustrophobia

Brief summary

This study evaluates if our Virtual Reality (VR) simulation inside the MRI efficiently alleviates symptoms of claustrophobia for patients during the MRI examination.

Detailed description

Anxiety of claustrophobic patients during MRI scan leads to movements of patients (which cause imaging artefacts), interruptions or even abortions of imaging scans, eventually requiring to reschedule the examination. Improving these symptoms by creating a VR experiences adapted to the physical constraints of the MRI environment, such as disappearing the scanner, not only improves the subjective experience of the participant, but has immediate impacts the time spent on the examination, on personnel costs, and resource availability (scanner time). This study aims at comparing claustrophobic patients in an A\|B group design with or without VR intervention. Primary outcomes include subjective reports from patients (Acceptability and Demand) and practitioners (Implementation, Practicality, Adaptation, Integration, Expansion). Secondary outcomes include scanning efficacy based e.g. on the imaging quality, number of times a scan is interrupted by the user and the total duration of a scan. Another non-claustrophobic patients' group will be tested for for obtaining feedback on the general benefit of VR immersion on patients' experience.

Interventions

DEVICEImmersion in virtual reality using Nordic Neurolab(™) Visual System

In addition to the standard MRI procedure, the VR intervention group will be looking at stereoscopic computer generated images through a pair of head-coil-mounted googles (Nordic Neurolab ™ Visual System). Two markers (color balls) will be fixed on their knees to capture their movement (camera tracking from the outside of the MRI room). The VR scenario will consist in showing a replication of the actual MRI examination room, as seen from the point of view of the participant lying on the MRI bed, but without the MRI tunnel. Participant can see themselves in the large room (a simplified gender-matched avatar), and an entertaining video can be displayed.

Sponsors

University Hospital, Geneva
CollaboratorOTHER
Ecole Polytechnique Fédérale de Lausanne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Intervention model description

Invervention group / no intervention group (standard of care)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* indicating suffering from claustrophobia * Be aged between 18 and 40 year-old * Being able to give consent * Being able to understand and speak French or English * Being MRI-compatible

Exclusion criteria

* Epilepsy or illnesses affecting the brain, such as HIV, Lyme disease or meningitis * Psychiatric disorders, such as schizophrenia, autism, obsessive compulsive disorder. * History of 1 year or more of addiction to drugs such as cannabis, alcohol, cocain, heroine, LSD. * Taking sleeping pills or anti-anxiety medication before the exam

Design outcomes

Primary

MeasureTime frameDescription
Anxiety levelthrough study completion, an average of one yearQuestionnaire on anxiety during scan (9 items)
Interruptionthrough study completion, an average of one yearRecord of interruption due to claustrophobia during MRI scan

Secondary

MeasureTime frameDescription
MRI Image qualitythrough study completion, an average of one yearEvaluation of MRI image quality for medical care

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026